News

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of PAREXEL Functional Services within the Company?s Clinical Research Services business segment.

PRA International(?PRA?), a leading clinical research organization,today announced that funds managed by KKR, a leading global investment firm, are acquiring PRA from Genstar Capital, LLC (?Genstar?), a private equity firm based in San Francisco.

Genetic Alliance, a non-profit health advocacy organization committed to enabling individuals to be full participants in clinical research, is joining the Oracle Health Sciences Network to create a bridge linking individuals in its crowd-sourced patient registry to clinical trials.

INC ResearchLLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process? for delivering reliable results, today announced it has attained four new accreditations in the Medidata Clinical Cloud?, further reinforcing its focus on innovation to help biopharmaceutical companies overcome critical cost, risk and efficiency challenges across the clinical chain.

Greenphire, a provider of payment technologies for the clinical trials industry, announced a relationship with Oracle Health Sciences.

The WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services for human research, announced that it has partnered with UL Quality, Compliance and Learning (formerly EduNeering), a provider of technology-driven compliance learning solutions to bring educational opportunities to clinical research professionals.

Gamification is the application of game elements and game design techniques to non-game problems.

Novotech, Australia?s largest clinical CRO has expanded its Asia reach into Hong Kong and the Philippines, building on its established network which already includes a presence in Singapore, South Korea, Taiwan, Thailand, India and Malaysia.

Next week at DIA, two of TransCelerate?s Risk Based Monitoring workstream members will take their newly released methodology to the people.

TransCelerate BioPharma Inc. ("TransCelerate") today announced that it has reached several important milestones in its initiative to realize efficiencies across clinical trial investigator and site qualification and training ("SQT") efforts.

Senior clinical executives from top pharmaceutical companies, including AstraZeneca and GlaxoSmithKline (GSK), alongside leading contract research organizations and representatives from the Association of Clinical Research Professionals (ACRP) and CenterWatch, met recently to set the quality standards and define the competencies for a global competition to recognize and encourage talented researchers in North and South America.

With ISR?s newest market research report (?Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing?) Mr. Schafer is back to draw comparisons and share data from their latest survey.

Next week at DIA, two of TransCelerate?s Risk Based Monitoring workstream members will take their newly released methodology to the people.

The Supreme Court decision blocking patents on naturally-occurring genes has generated predictions of doom for biotech innovation, along with expectations of more healthy competition in discovering new treatments and diagnostics.